Sort
30,917 grants matching “tumor microenvironment”
Micro- and nanofiber enabled biomimetic periosteum for bone repair and reconstruction
$563,945Xinping Zhang · University Of Rochester · R01 · FY2018 · AR
Micro- and nanofiber enabled biomimetic periosteum for bone repair and reconstruction
$563,945Xinping Zhang · University Of Rochester · R01 · FY2020 · AR
Micro- and nanofiber enabled biomimetic periosteum for bone repair and reconstruction
$563,945Xinping Zhang · University Of Rochester · R01 · FY2019 · AR
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models
$563,937Nimmi Ramanujam · Duke University · R01 · FY2021 · EB
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
$563,902Michael Karin · University Of California, San Diego · R01 · FY2023 · CA
Development of novel protein-based therapeutics for lung cancer
$563,856Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2021 · CA
Next generation oncolytic virotherapy targeting AKT and ERK signaling in glioma
$563,850Balveen Kaur · Augusta University · R01 · FY2024 · NS
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
$563,847Pepper J Schedin · Oregon Health & Science University · R01 · FY2017 · CA
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer
$563,811Deborah W Knapp · Purdue University · U01 · FY2022 · CA
Integrating cancer genomics and spatial architecture of tumor infiltrating lymphocytes
$563,786Hanlee Ji · Stanford University · R01 · FY2025 · CA
Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations
$563,735Mark R. Kelley · Indiana University Indianapolis · R01 · FY2019 · CA
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
$563,723John Kurhanewicz · University Of California, San Francisco · R01 · FY2013 · CA
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
$563,656Christiane Querfeld · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
$563,656Christiane Querfeld · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Project 1 Mouse Models Analysis
$563,617Edgar G. Engleman · Stanford University · U54 · FY2023 · CA
Hydrogel-based Organoids of African-American Lymphomas to Study B Cell Receptor Pathway Inhibitors
$563,593Ankur Singh · Georgia Institute Of Technology · R01 · FY2022 · CA
Novel Markers for Disease Outcome in Breast Cancer
$563,569Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Understanding and targeting bone marrow microenvironment in myelofibrosis
$563,550Lei Ding · Columbia University Health Sciences · R01 · FY2024 · HL
A pH Responsive Transistor-like Nanoprobe for Sensitive Detection of Unknown Primary Cancers of the Head and Neck
$563,527Baran D Sumer · Ut Southwestern Medical Center · R01 · FY2025 · CA
Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer
$563,472Kyung Hyun Sung · University Of California Los Angeles · R01 · FY2025 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis
$563,435Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Data Science Core
$563,404Ming Li · University Of Southern California · P30 · FY2022 · CA
Development of novel protein-based therapeutics for lung cancer
$563,401Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2020 · CA
BMP2 Regulation of Periosteal Function
$563,348Vicki Rosen · Harvard Medical School · R01 · FY2023 · AR
Fluorescent Indocarbocyanine PEGylated Lipid Nanoparticles for Understanding and Overcoming Barriers to Drug Delivery in Invasive Glioblastoma
$563,302Dmitri Simberg · University Of Colorado Denver · R01 · FY2023 · CA